- Abstract
- 1. Introduction
- 2. Material and Methods
- 2.1. Template Selection
- 2.2. Homology and Threading based Modeling of CysLT1
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A100492812
Sathya Babu (Department of Bioinformatics, School of Bioengineering, SRM University) ; Thirumurthy Madhavan (Department of Bioinformatics, SRM University, SRM Nagar, Kattankulathur)
2015
English
405
KCI등재후보
학술저널
13-18(6쪽)
6
0
상세조회0
다운로드목차 (Table of Contents)
참고문헌 (Reference)
1 C. Colovos, "Verification of protein structures : patterns of non-bonded atomic interactions" 2 : 1511-1519, 1993
2 Y. Ogawa, "The role of leukotrienes in airway inflammation" 118 : 789-798, 2006
3 H. M. Berman, "The protein data bank" 28 : 235-242, 2000
4 X. Dong, "Structure-based drug design using GPCR homology modeling : Toward the discovery of novel selective CysLT2 antagonists" 62 : 754-763, 2013
5 S. C. Lovell, "Structure validation by Cα geometry : φ, ψ and Cβ deviation" 50 : 437-450, 2003
6 P. Montuschi, "Pharmacological modulation of leukotriene pathway in allergic airway disease" 12 : 404-412, 2007
7 V. Capra, "Molecular and functional aspects of human cysteinyl leukotriene receptors" 50 : 1-11, 2004
8 J. C. Mobarec, "Modern homology modeling of G-protein coupled receptors : which structural template to use?" 52 : 5207-5216, 2009
9 H. M. Sarau, "Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor" 56 : 657-663, 1999
10 Y. Zhang, "I-TASSER server for protein 3D structure prediction" 9 : 1-8, 2008
1 C. Colovos, "Verification of protein structures : patterns of non-bonded atomic interactions" 2 : 1511-1519, 1993
2 Y. Ogawa, "The role of leukotrienes in airway inflammation" 118 : 789-798, 2006
3 H. M. Berman, "The protein data bank" 28 : 235-242, 2000
4 X. Dong, "Structure-based drug design using GPCR homology modeling : Toward the discovery of novel selective CysLT2 antagonists" 62 : 754-763, 2013
5 S. C. Lovell, "Structure validation by Cα geometry : φ, ψ and Cβ deviation" 50 : 437-450, 2003
6 P. Montuschi, "Pharmacological modulation of leukotriene pathway in allergic airway disease" 12 : 404-412, 2007
7 V. Capra, "Molecular and functional aspects of human cysteinyl leukotriene receptors" 50 : 1-11, 2004
8 J. C. Mobarec, "Modern homology modeling of G-protein coupled receptors : which structural template to use?" 52 : 5207-5216, 2009
9 H. M. Sarau, "Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor" 56 : 657-663, 1999
10 Y. Zhang, "I-TASSER server for protein 3D structure prediction" 9 : 1-8, 2008
11 A. Maekawa, "GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4" 106 : 11685-11690, 2009
12 C. Parravicini, "GPR17 : Molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors" 9 : 263-, 2008
13 G. Woszczek, "Functional characterization of human cysteinyl leukotriene 1 receptor gene structure" 175 : 5152-5159, 2005
14 M. Bäck, "Functional characteristics of cysteinylleukotriene receptor subtypes" 71 : 611-622, 2002
15 C. Corrigan, "Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis" 115 : 316-322, 2005
16 B. K. Kuntal, "Easy-Modeller : A graphical interface to MODELLER" 3 : 226-, 2010
17 Y. Kanaoka, "Cysteinyl leukotrienes and their receptors : cellular distribution and function in immune and inflammatory responses" 173 : 1503-1510, 2004
18 J. Theron, "Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function" 1-16, 2014
19 Y. Hui, "Cysteinyl leukotriene receptor" 64 : 1549-1557, 2002
20 N. Eswar, "Comparative protein structure modeling with MODELLER" 5 : 1-5, 2006
21 J. D. Thompson, "CLUSTAL W : improving the sensitivity of progressive sequence weighting, position-specific gap penalties and weight matrix choice" 22 : 4673-4680, 1994
22 S. F. Altschul, "Basic local alignment search tool" 215 : 403-410, 1990
A CoMFA Study of Glycogen Synthase Kinase 3 Inhibitors
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2022 | 평가예정 | 신규평가 신청대상 (신규평가) | |
2021-12-01 | 평가 | 등재후보 탈락 (계속평가) | |
2020-12-01 | 평가 | 등재후보로 하락 (재인증) | |
2017-01-01 | 평가 | 등재학술지 유지 (계속평가) | |
2013-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2012-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
2010-01-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.45 | 0.45 | 0.35 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.28 | 0.25 | 0.24 | 0.05 |